Skip to content
Preprint · CC-BY via OpenAlex

Thymulin at the crossroads of inflammaging and Cancer: An emerging immunoregulatory Axis

Ghezal Dabiry, Abiya Ahad, Sultan Mujib Dabiry, Tala Nuray Yusufoğlu, Ananya Katoch, Zafer Utku Ulker, Raghad Zaidan

· 2026

Abstract

This scoping review will map and synthesize the existing evidence on thymulin in relation to inflammaging(definition) and cancer, with particular emphasis on its potential role as an immunoregulatory mediator at the intersection of chronic inflammation, immune aging, and tumor biology. The review will examine the available evidence regarding thymulin’s biological functions, its relationship with age-associated immune dysregulation and chronic low-grade inflammation, and its potential involvement in cancer-related immune responses. The review will identify and characterize the existing literature addressing thymulin in the context of aging, inflammaging, cancer development or progression, immune regulation, and related molecular and cellular pathways. Where available, evidence concerning thymulin levels, regulatory mechanisms, cellular targets, signaling pathways, and associations with clinical or biological outcomes will also be mapped. The primary objective is to provide a comprehensive overview of the current state of knowledge, identify areas of convergence and uncertainty, and highlight gaps in the literature that may guide future mechanistic and translational research. Given the emerging nature and heterogeneity of the evidence base, the review will use a scoping review methodology to characterize the breadth, nature, and distribution of available evidence rather than to estimate a pooled effect.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.17605/osf.io/vxrdm
Canonical
link ↗
Fetched
2026-10-06 MST

Cite this

APA
Dabiry, G., Ahad, A., Dabiry, S.M., Yusufoğlu, T.N., Katoch, A., Ulker, Z.U., & Zaidan, R. (2026). Thymulin at the crossroads of inflammaging and Cancer: An emerging immunoregulatory Axis. https://doi.org/10.17605/osf.io/vxrdm
Vancouver
Dabiry G, Ahad A, Dabiry SM, Yusufoğlu TN, Katoch A, Ulker ZU, et al. Thymulin at the crossroads of inflammaging and Cancer: An emerging immunoregulatory Axis. 2026. doi:10.17605/osf.io/vxrdm.
BibTeX
@unpublished{ghezal2026Thymul, title = {Thymulin at the crossroads of inflammaging and Cancer: An emerging immunoregulatory Axis}, author = {Ghezal Dabiry and Abiya Ahad and Sultan Mujib Dabiry and Tala Nuray Yusufoğlu and Ananya Katoch and Zafer Utku Ulker and Raghad Zaidan}, year = {2026}, doi = {10.17605/osf.io/vxrdm}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings